Cargando…
Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
PURPOSE: In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [(18)F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment. METHODS: Twenty-five patients with s...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113306/ https://www.ncbi.nlm.nih.gov/pubmed/33336264 http://dx.doi.org/10.1007/s00259-020-05137-7 |